[1]
|
Pearce, J., Hawton, K. and Blake, F. (1995) Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. British Journal of Psychiatry, 167, 163-173.
doi:10.1192/bjp.167.2.163
|
[2]
|
Dennerstein, L. (1996) Well-being, symptoms and the menopausal transition. Maturitas, 23, 147-157.
doi:10.1016/0378-5122(95)00970-1
|
[3]
|
Rossouw, J., Anderson, G., Prentice, R., LaCroix, A., Kooperberg, C., Stefanick, M., Jackson, R., Beresford, S., Howard, B., Johnson, K., Kotchen, J. and Ockene, J. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women’s health initiative randomized controlled trial. Journal American Medical Association, 288, 321-333.
doi:10.1001/jama.288.3.321
|
[4]
|
Dobkin, D., Menza, M., Allen, L., Marin, H., Bienfait, K., Tiu, J. and Howarth, J. (2009) Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study. Annals of Clinical Psychiatry, 21, 70-76.
|
[5]
|
Vickers, M., MacLennan, A., Lawton, B., Ford, D., Martin, J., Meredith, S., DeStavola, B., Rose, S., Dowell, A., Wilkes, H., Darbyshire, J. and Meade, T. (2007) Main morbidities recorded in the women’s international study of long duration oestrogen after menopause (WISDOM): A randomised controlled trial of hormone replacement therapy in postmenopausal women. British Medical Journal, 335, 239-244. doi:10.1136/bmj.39266.425069.AD
|
[6]
|
Rodriguez, C., Patel, A., Calle, E., Jacob, E. and Thun, M. (2001) Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. Journal American Medical Association, 285, 1460-1465.
doi:10.1001/jama.285.11.1460
|
[7]
|
Shumaker, S., Legault, C., Rapp, S., Thal, L., Wallace, R., Ockene, J., Hendrix, S., Jones, B.r., Assaf, A., Jackson, R., Kotchen, J., Wassertheil-Smoller, S. and Wactawski-Wende, J. (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The women’s health initiative memory study: A randomized controlled trial. The Journal of American Medical Association, 289, 2651-2662.
doi:10.1001/jama.289.20.2651
|
[8]
|
Fletcher, S. and Colditz, G. (2002) Failure of estrogen plus progestin therapy for prevention. The Journal of American Medical Association, 288, 366-368.
doi:10.1001/jama.288.3.366
|
[9]
|
Nelson, H., Humphrey, L., Nygren, P., Teutsch, S. and Allan, J. (2002) Postmenopausal hormone replacement therapy: Scientific review. The Journal of American Medical Association, 288, 872-881.
doi:10.1001/jama.288.7.872
|
[10]
|
Boraz, M.A., Simkin-Silverman, L.R., Wing, R.R., Meilahn, E.N. and Kuller, L.H. (2001) Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention. Preventive Medicine, 33, 108-114.
doi:10.1016/S0091-7435(01)80006-2
|
[11]
|
Imai, A., Matsunami, K. and Takagi, H., Ichigo, S. (2012) New generation nonhormonal management for hot flashes. Gynecologic Endocrinology, in press.
doi:10.3109/09513590.2012.705380
|
[12]
|
Loprinzi, C., Sloan, J., Stearns, V., Slack, R., Iyengar, M., Diekmann, B., Kimmick, G., Lovato, J., Gordon, P., Pandya, K., Guttuso, T.J., Barton, D. and Novotny, P. (2009) Newer antidepressants and gabapentin for hot flashes: An individual patient pooled analysis. Journal of Clinical Oncology, 27, 2831-2837.
doi:10.1200/JCO.2008.19.6253
|
[13]
|
Pinkerton, J., Stovall, D. and Kightlinger, R. (2009) Advances in the treatment of menopausal symptoms. Women’s Health, 5, 361-384. doi:10.2217/whe.09.31
|
[14]
|
Sideras, K. and Loprinzi, C. (2010) Nonhormonal management of hot flashes for women on risk reduction therapy. Journal of National Comprehensive Cancer Network, 8, 1171-1179.
|
[15]
|
Loprinzi, C., Qin, R., Balcueva, E., Flynn, K., Rowland, K.J., Graham, D., Erwin, N., Dakhil, S., Jurgens, D. and Burger, K. (2010) Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. Journal of Clinical Oncology, 28, 641-647. doi:10.1200/JCO.2009.24.5647
|
[16]
|
Freeman, E., Guthrie, K., Caan, B., Sternfeld, B., Cohen, L., Joffe, H., Carpenter, J., Anderson, G., Larson, J., Ensrud, K., Reed, S., Newton, K., Sherman, S., Sammel, M. and LaCroix, A. (2011) Efficacy of escitalopram for hot flashes in healthy menopausal women: A randomized controlled trial. The Journal of American Medical Association, 305, 267-274. doi:10.1001/jama.2010.2016
|
[17]
|
Soares, C., Arsenio, H., Joffe, H., Bankier, B., Cassano, P., Petrillo, L. and Cohen, L. (2006) Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: Impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause, 13, 780-786.
doi:10.1097/01.gme.0000240633.46300.fa
|
[18]
|
Soares, C., Thase, M., Clayton, A., Guico-Pabia, C., Focht, K., Jiang, Q., Kornstein, S., Ninan, P., Kane, C. and Cohen, L. (2010) Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder. Menopause, 17, 700-711.
|
[19]
|
Sloan, J., Loprinzi, C., Novotny, P., Barton, D., Lavasseur, B. and Windschitl, H. (2001) Methodologic lessons learned from hot flash studies. Journal of Clinical Oncology, 19, 4280-4290.
|